Efficacy and safety of hyperthermic intraperitoneal chemotherapy in treatment of primary or recurrent ovarian cancer: systematic review and meta-analysis. [PDF]
Al Ameer AA +7 more
europepmc +1 more source
Prevalence and risk factors for postoperative incisional hernia after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta‑analysis and systematic review. [PDF]
Zeng Q, Yuan X, Wei X.
europepmc +1 more source
Thermally enhanced efficacy of chemotherapy potentiates cisplatin-based hyperthermic intraperitoneal chemotherapy in ovarian cancer. [PDF]
Yang F +9 more
europepmc +1 more source
Experiences of Fundamental Care Needs After Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy: A Qualitative Study. [PDF]
Bangsparr P, Jakobsson J.
europepmc +1 more source
Liposomal Bupivacaine Incisional Infiltration for Postoperative Analgesia After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Randomized Placebo-Controlled Trial. [PDF]
Zhang H +8 more
europepmc +1 more source
Predicting PPOI secondary to laparoscopic radical resection of rectal cancer combined with lobaplatin hyperthermic intraperitoneal chemotherapy: a multi-center study. [PDF]
Zhang W +12 more
europepmc +1 more source
Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: <i>A single-institution case series</i>. [PDF]
Ravi PR +4 more
europepmc +1 more source
Association of the Preoperative CALLY Index with Acute Kidney Injury After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Comparison with Other Inflammatory and Immune-Nutritional Indices. [PDF]
Şahin H +7 more
europepmc +1 more source
Tertiary cytoreduction for recurrence of ovarian CANCER patients after intraperitoneal chemotherapy. [PDF]
Santangelo G +10 more
europepmc +1 more source

